Literature DB >> 2491838

Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon.

H Toba1, J T Crawford, J J Ellner.   

Abstract

Mycobacterium avium is a frequent opportunistic pathogen in the acquired immunodeficiency syndrome (AIDS). We compared 12 strains of M. avium in an in vitro model of pathogenicity. Peripheral blood-derived monocytes from healthy individuals were infected with M. avium in vitro. Bacterial uptake and intracellular replication were assessed by microscopic count of acid-fast bacilli and CFU of bacteria, respectively, in lysed monocytes. The CFU assay showed that among five AIDS-associated strains, only one replicated in monocytes. Two of seven non-AIDS-associated strains replicated intracellularly. In addition, we examined the effect of gamma interferon (IFN-gamma) on M. avium infection. IFN-gamma treatment of monocytes decreased phagocytosis and had no effect on the intracellular replication of M. avium. Thus, most strains of M. avium do not multiply within monocytes from healthy individuals and IFN-gamma does not have macrophage-activating factor activity for M. avium infection of human monocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2491838      PMCID: PMC313080          DOI: 10.1128/iai.57.1.239-244.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Interferon-gamma-activated human monocytes inhibit the intracellular multiplication of Legionella pneumophila.

Authors:  N Bhardwaj; T W Nash; M A Horwitz
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

2.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.

Authors:  G A Rook; J Steele; M Ainsworth; B R Champion
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

3.  Preliminary demonstration of human tuberculoimmunity in vitro.

Authors:  A J Crowle; M May
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

4.  Analysis of plasmids in Mycobacterium avium-intracellulare isolates from persons with acquired immunodeficiency syndrome.

Authors:  J T Crawford; J H Bates
Journal:  Am Rev Respir Dis       Date:  1986-10

5.  Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi.

Authors:  C A Nacy; M S Meltzer
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

7.  Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.

Authors:  C A Nacy; M S Meltzer; E J Leonard; D J Wyler
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

8.  Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.

Authors:  A J Crowle; A Y Tsang; A E Vatter; M H May
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

9.  Evidence for plasmid-mediated restriction-modification in Mycobacterium avium intracellulare.

Authors:  J T Crawford; M D Cave; J H Bates
Journal:  J Gen Microbiol       Date:  1981-12

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  23 in total

1.  Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha).

Authors:  K Sato; T Akaki; H Tomioka
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

2.  Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages.

Authors:  G Källenius; T Koivula; K J Rydgård; S E Hoffner; A Valentin; B Asjö; C Ljungh; U Sharma; S B Svenson
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Down regulation of macrophage activation in Brugia pahangi-infected jirds (Meriones unguiculatus).

Authors:  C Nasarre; J L Krahenbuhl; T R Klei
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Ultraviolet-irradiated monocytes efficiently inhibit the intracellular replication of Mycobacterium avium intracellulare.

Authors:  W S Mirando; H Shiratsuchi; K Tubesing; H Toba; J J Ellner; C A Elmets
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

5.  Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.

Authors:  M Denis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

6.  Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamellar structure: freeze fracture analysis of infected mouse liver.

Authors:  S Rulong; A P Aguas; P P da Silva; M T Silva
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Search for the molecular basis of morphological variation in Mycobacterium avium.

Authors:  S Prinzis; B Rivoire; P J Brennan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Envelope glycoprotein (gp120) from HIV-1 enhances Mycobacterium avium growth in human bronchoalveolar macrophages; an effect mediated by enhanced prostaglandin synthesis.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

9.  Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor.

Authors:  S K Furney; P S Skinner; A D Roberts; R Appelberg; I M Orme
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Human macrophages acquire a hyporesponsive state of tumor necrosis factor alpha production in response to successive Mycobacterium avium serovar 4 stimulation.

Authors:  H Gan; G W Newman; H G Remold
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.